Not applicableEnded earlyNCT03704285What this trial is testingDevelopment of pk/pd Model of Propofol in Patients With Severe BurnsWho this might be right forAnesthesiaBurnedOperative Wound Victor Contreras, MSN 15
Early research (Phase 1)Study completedNCT00457782What this trial is testingA Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaWho this might be right forMultiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)Ended earlyNCT05388435What this trial is testingSafety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors PatientsWho this might be right forAdvanced Solid Tumor SK Life Science, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00574210What this trial is testingPK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)Who this might be right forSeasonal Allergic RhinitisHay FeverRhinoconjunctivitis Faes Farma, S.A. 502
Early research (Phase 1)Study completedNCT01870674What this trial is testingSafety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male SubjectsWho this might be right forHealthy Yuhan Corporation 127
Early research (Phase 1)Ended earlyNCT03943550What this trial is testingDouble-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Hoffmann-La Roche 45
Early research (Phase 1)Study completedNCT01835197What this trial is testingFirst-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese SubjectsWho this might be right forHealthy Pfizer 79
Not applicableStudy completedNCT02588118What this trial is testingGender and PK-PD of Propofol and CisatracuriumWho this might be right forGender Medical University of Graz 120
Early research (Phase 1)Study completedNCT02571855What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly SubjectsWho this might be right forHealthy Subjects Idorsia Pharmaceuticals Ltd. 85
Early research (Phase 1)Study completedNCT05006521What this trial is testingSingle and Multiple Ascending Dose Study of KN-002Who this might be right forAsthma COPD Kinaset Therapeutics Inc 117
Testing effectiveness (Phase 2)Study completedNCT02079896What this trial is testingLexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis PatientsWho this might be right forAnemiaEnd Stage Renal Disease TME Pharma AG 33
Early research (Phase 1)Study completedNCT03062956What this trial is testingA Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491Who this might be right forDilated Cardiomyopathy MyoKardia, Inc. 64
Early research (Phase 1)Ended earlyNCT03907202What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DMWho this might be right forType II Diabetes Mellitus KeyBioscience AG 25
Not applicableNot Yet RecruitingNCT06319677What this trial is testingPK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation TreatmentWho this might be right forCritical IllnessExtracorporeal Membrane Oxygenation Complication The Third Xiangya Hospital of Central South University 50
Early research (Phase 1)Looking for participantsNCT07366866What this trial is testingSafety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.Who this might be right forAutoimmune Disease Changchun GeneScience Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Looking for participantsNCT07368127What this trial is testingTPD3310 in Patients With Advanced Malignant TumorsWho this might be right forAdvanced Malignant Solid Tumors TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. 112
Early research (Phase 1)Study completedNCT05723510What this trial is testingPK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy VolunteersWho this might be right forHealthy HK inno.N Corporation 87
Early research (Phase 1)Study completedNCT03522506What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy AdultsWho this might be right forHealthy Volunteers Takeda 20
Testing effectiveness (Phase 2)Study completedNCT03268941What this trial is testingEvaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)Who this might be right forDiabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis Millennium Pharmaceuticals, Inc. 51
Early research (Phase 1)Study completedNCT02148185What this trial is testingPharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Tanabe Pharma Corporation 1